상세 보기
Ustekinumab and immunomodulatory combination therapy is more effective than Ustekinumab monotherapy to prevent relapse in Crohn's patients classified as low to intermediate-probability responders by UST-CDST
- Song, J. H.;
- Shin, J.;
- Seong, G.;
- Kong, S. M.;
- Cha, B.;
- ... Kwon, K. S.;
- 외 1명
Citations
WEB OF SCIENCE
0- 제목
- Ustekinumab and immunomodulatory combination therapy is more effective than Ustekinumab monotherapy to prevent relapse in Crohn's patients classified as low to intermediate-probability responders by UST-CDST
- 저자
- Song, J. H.; Shin, J.; Seong, G.; Kong, S. M.; Cha, B.; Hong, J. T.; Kwon, K. S.
- 발행일
- 2024-01
- 유형
- Meeting Abstract
- 권
- 18
- 페이지
- I1663 ~ I1663
- 언어
- ENG
- 출판사
- Oxford University Press
- 발행국가
- 영국
- ISSN
- E 1876-4479
P 1873-9946